Sapna Yadavilli

The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4

Li Liu, Patrick A. Mayes, Stephen D. Eastman et al. · Clinical Cancer Research · 2015 · 440 citations

Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments

Jong W. Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra et al. · PLoS ONE · 2018 · 197 citations · Full text

Unique Tumor-immune Infiltrate, Novel Anti-cancer Immunotherapies, Immunology +17

Immunodynamics of explanted human tumors for immuno‐oncology

Agathe Dubuisson, Jean‐Eudes Fahrner, Anne‐Gaëlle Goubet et al. · EMBO Molecular Medicine · 2020 · 37 citations · Full text

CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas

Kieu-Suong Le, Patricia Amé-Thomas, Karin Tarte et al. · Blood Advances · 2018 · 36 citations · Full text

Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade

Sapna Yadavilli, Jeremy D. Waight, Sara Brett et al. · Cancer Research Communications · 2023 · 15 citations · Full text